Centiva Capital’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$254K Sell
3,111
-1,953
-39% -$137K ﹤0.01% 1264
2026
Q1
$289K Buy
+5,064
New +$294K ﹤0.01% 1082
2025
Q1
Sell
-6,460
Closed -$253K 2011
2024
Q4
$253K Buy
+6,460
New +$232K 0.01% 1237
2024
Q2
Sell
-5,916
Closed -$211K 2419
2024
Q1
$211K Buy
+5,916
New +$214K 0.01% 1442
2023
Q3
Sell
-9,686
Closed -$339K 2008
2023
Q2
$339K Buy
+9,686
New +$309K 0.01% 1051
2021
Q4
Sell
-4,687
Closed -$312K 1476
2021
Q3
$312K Sell
4,687
-533
-10% -$41.6K 0.02% 772
2021
Q2
$479K Buy
+5,220
New +$514K 0.01% 850

Other funds holding PRLB

Centiva Capital's PRLB Position: Q2 2026 in Review

Centiva Capital reduced its Protolabs (PRLB) stake by 39% in Q2 2026, selling an estimated $137K and leaving 3,111 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #1264.

Centiva Capital first reported a position in PRLB in Q2 2021 and has held it in 7 quarters since. The position peaked at $479K in Q2 2021. 277 funds tracked by Wall St. Rank hold PRLB as of Q2 2026.

  • Centiva Capital held 3,111 shares of Protolabs worth $254K as of Q2 2026.
  • Centiva Capital sold 1,953 Protolabs shares in Q2 2026, an estimated $137K.
  • Protolabs made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1264 holding.
  • Centiva Capital first reported a position in Protolabs in Q2 2021 and has held it in 7 quarters since.
  • Centiva Capital's Protolabs position peaked at $479K in Q2 2021.
  • 277 funds tracked by Wall St. Rank held Protolabs as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.